Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
MEI Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MEIP
Nasdaq
8731
https://www.meipharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for MEI Pharma Inc
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344
- Apr 11th, 2024 12:02 pm
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (AvastinĀ®) in Relapsed Metastatic Colorectal Cancer Patients
- Apr 11th, 2024 12:00 pm
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- Apr 10th, 2024 12:00 pm
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
- Mar 26th, 2024 12:00 pm
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
- Mar 9th, 2024 6:09 pm
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
- Feb 13th, 2024 11:15 pm
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
- Feb 13th, 2024 10:05 pm
Is MEI Pharma (MEIP) Attractively Priced?
- Feb 8th, 2024 11:48 am
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
- Jan 16th, 2024 10:00 pm
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
- Dec 11th, 2023 5:00 pm
11 Cheapest Stocks With Biggest Upside
- Nov 27th, 2023 3:33 pm
AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer
- Nov 17th, 2023 1:06 pm
Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises
- Nov 10th, 2023 4:09 pm
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
- Nov 9th, 2023 9:05 pm
Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated
- Nov 9th, 2023 6:02 pm
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
- Nov 8th, 2023 1:00 pm
Axsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates
- Nov 7th, 2023 4:02 pm
MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock
- Nov 6th, 2023 9:57 pm
Corcept (CORT) Beats on Q3 Earnings, Raises '23 Sales View
- Nov 2nd, 2023 3:23 pm
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
- Nov 2nd, 2023 1:00 pm
Scroll